return to news
  1. Top gainers and losers, October 30: Dr Reddy's Labs, Cipla, HDFC Life fall over 2%, check full list

Market News

Top gainers and losers, October 30: Dr Reddy's Labs, Cipla, HDFC Life fall over 2%, check full list

Upstox

6 min read | Updated on October 30, 2025, 16:16 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Dr Reddy's Labs was top loser in the NIFTY50 index, the stock fell 3.79% to close at ₹1,203.50 after it received a notice of non-compliance from Canadian drug authority for Semaglutide injection which is sold under the brand names Ozempic and Wegovy.

Stock list

CIPLA
--
HDFCLIFE
--
gainers and losers

The SENSEX ended 593 points lower at 84,404. Image: Shutterstock

The Indian equity benchmarks ended sharply lower on Thursday, October 30, amid heightened volatility due to monthly expiry of SENSEX October futures & option contracts.

Open FREE Demat Account within minutes!
Join now

The SENSEX fell as much as 684 points and NIFTY50 index touched an intraday low of 25,845 dragged down by HDFC Bank, Reliance Industries, Bharti Airtel, Infosys, ICICI Bank, Mahindra & Mahindra and Bajaj Finance.

The SENSEX ended 593 points lower at 84,404 and NIFTY50 index declined 176 points to close at 25,878.

NIFTY50 gainers and losers

Dr Reddy's Labs was top loser in the NIFTY50 index, the stock fell 3.79% to close at ₹1,203.50 after it received a notice of non-compliance from Canadian drug authority for Semaglutide injection which is sold under the brand names Ozempic and Wegovy.

Dr Reddy's Labs shares dropped as much as 5.72%, their biggest single day fall since May, 11, 2023, to hit an intraday low of ₹1,180.90 on the National Stock Exchange.

"We have received a Notice of Non-Compliance (NON) from Pharmaceutical Drugs Directorate, Canada, regarding our Abbreviated New Drug Submission (ANDS) for Semaglutide Injection. The NON outlines requests for additional information & clarifications on specific aspects of the submission. We will submit a response at the earliest and well within the stipulated time period," Dr Reddy's Labs said in an exchange filing.

Cipla declined 2.54% after reported its second quarter results for the 2025-26 financial year (Q2FY26) on Thursday, October 30, posting a 3.73% year-on-year (YoY) increase in its consolidated net profit to ₹1,351.17 crore.

In the corresponding period of the last fiscal year, it had clocked a profit of ₹1,302.53 crore, the firm said in a regulatory filing.

Cipla witnessed a 7.63% YoY surge in its total revenue from operations to ₹7,589.44 crore during the quarter under review, compared to ₹7,051.02 crore in the September quarter of the 2024-25 fiscal year (Q2FY25).

HDFC Life (-2.01%), InterGlobe Aviation (-1.68%) and Bharti Airtel (-1.5%) were also among the losers.

On the other hand, Coal India (1.58%), Larsen & Toubro (0.79%), Hindalco (0.79%), Bharat Electronics (0.74%) and Nestle India (0.55%) were gainers in the NIFTY50 index.

NIFTY Midcap 100 gainers and losers

NIFTY Midcap 100 index fell 0.09% or 53 points to close at 60,096. As many as 66 shares ended lower while 34 closed lower.

Vodafone Idea was top loser in the NIFTY Midcap 100 index, the stock fell 6.52% to close at ₹8.75 after the Supreme Court’s written order on the telecom company’s AGR dues created concerns and uncertainty.

The Supreme Court’s order allowing the government to review the adjusted gross revenue (AGR) dues applies only to the additional dues from 2016–17, according to the order copy. Earlier, on October 27, reports said the Centre was open to reconsidering Vodafone Idea’s request in the AGR case, and the Court allowed it since the matter falls under the government’s policy domain.

Coromandel International fell 3.8% after its second quarter earnings failed to enthuse investors.

LIC Housing Finance declined 3.61% after it posted a 2% year-on-year (YoY) fall in its standalone net profit to ₹1,353.87 crore in the September quarter of FY26, compared to ₹1,328.89 crore in the corresponding quarter of the previous fiscal year.

Its net interest income (NII) stood at ₹2,038 crore during the quarter under review, marking a 3% YoY increase from ₹1,974 crore in the second quarter of the 2024-25 fiscal year (Q2FY25), it said in a regulatory filing late on Wednesday.

Indus Towers (-3.42%) and Bharti Hexacom (-2.76%) were also among the losers.

On the flipside, PB Fintech was top gainer in the NIFTY Midcap 100 index, the stock rose 6.88% to close at ₹1,842 after the company reported strong set of earnings in the second quarter of current financial year.

PB Fintech, which operates Policybazaar and Paisabazaar online portals, post market hours on Wednesday reported net profit of ₹135 crore in the second quarter of current financial year, marking an increase of 165% from ₹51 crore in the same period last year.

Its revenue from operations in July-September period advanced 38% to ₹1,614 crore from ₹1,167 crore.

PB Fintech reported strong operational performance as it reported an operational profit of ₹98 crore against operational loss of ₹8 crore.

BHEL rose 6.73% after its net profit skyrocketed 254% to ₹375 crore for the July to September quarter of financial year 2025-26 as compared to ₹106 crore in the same period of the previous fiscal year.

Aditya Birla Capital rose 5.21% after its net profit declined 15% to ₹855 crore.

Oil India (3.33%) and Hitachi Energy (2.53%) were also among the gainers.

NIFTY Smallcap 100 gainers and losers

NIFTY Smallcap 100 index declined 0.1% or 18 points to close at 18,470. As many as 60 shares in the index closed lower while 40 ended higher.

Indian Energy Exchange was top loser in the NIFTY Smallcap 100 index, the stock fell 3.57% to close at ₹143. Newgen Software (-2.89%), Amber Enterprises (-2.33%), Chambal Fertilisers (-2.18%) and Aegis Logistics (-2.15%) were also laggards in the NIFTY Smallcap 100 index.

On the contrary, Sagility was top gainer in the NIFTY Smallcap 100 index, the stock rose 7.9% to close at ₹54.89 after it consolidated net profit increased 114.5% to ₹251 crore for the July to September quarter of financial year 2025-26 as compared to ₹117 crore in the same period of the previous fiscal year.

The firm’s revenue from operations surged 25% year-on-year (YoY) to ₹1,658 crore in Q2 FY26 in contrast to ₹1,325 crore in the corresponding quarter of the previous financial year.

Sagility’s earnings before interest, tax, depreciation, and amortisation (EBITDA) also rose 38% to ₹416 crore for Q2 FY26 as compared to ₹301 crore in Q2 FY25.

Credit Access Graameen (5.29%), Five-Star Business Finance (5.28%), Neuland Labs (4.96%) and IIFL (3.64%) were also among the gainers.

Disclaimer: This article is purely for informational purposes and should not be considered investment advice from Upstox. Please consult with a financial advisor before making any investment decisions.
To add Upstox News as your preferred source on Google, click here.
SIP
Consistency beats timing.
promotion image

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story